Group 1 - The core viewpoint of the article highlights the recent trading activity of southbound funds in Baize Medical (02609.HK), indicating a net increase of 55.98 thousand shares on December 17, while also noting a cumulative net reduction of 74.4 thousand shares over the last five trading days and 198.78 thousand shares over the last twenty trading days [1] - As of now, southbound funds hold 61.51 million shares of Baize Medical, which represents 4.65% of the company's total issued ordinary shares [1] - Baize Medical Group primarily engages in investment and provision of medical-related services, focusing on oncology medical services throughout the entire cycle, including screening, diagnosis, treatment, and rehabilitation [1] Group 2 - The company's operations encompass hospital business, hospital management services, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - Services provided by the company include cancer diagnosis, treatment, rehabilitation, end-of-life care, early cancer screening, cancer vaccination, and health management services for potential healthy populations [1] - The company primarily conducts its business in the Chinese market [1]
佰泽医疗（02609.HK）：12月17日南向资金增持55.98万股